title: The use of itraconazole in the treatment of leishmaniasis caused by Leishmania aethiopica.
authors.affiliation: Department of Infectious Diseases, Karolinska Institute, Stockholm, Sweden.
authors.forename: H
authors.initials: H
authors.lastname: Akuffo
authors.forename: M
authors.initials: M
authors.lastname: Dietz
authors.forename: S
authors.initials: S
authors.lastname: Teklemariam
authors.forename: T
authors.initials: T
authors.lastname: Tadesse
authors.forename: G
authors.initials: G
authors.lastname: Amare
authors.forename: T Y
authors.initials: TY
authors.lastname: Berhan
mesh_terms: D000293:Adolescent; D000328:Adult; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D002648:Child; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D017964:Itraconazole; D007654:Ketoconazole / Q000031:analogs & derivatives* / Q000627:therapeutic use; D007896:Leishmaniasis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
chemical_list: D000981:Antiprotozoal Agents; D017964:Itraconazole; D007654:Ketoconazole